Stepan VP receives new equity awards in Form 4/A

STEPAN CO executive Sean Thomas Moriarty, VP & GM Surfactants, reported multiple equity-based compensation awards.

Rhea-AI Filing Summary

STEPAN CO executive Sean Thomas Moriarty, VP & GM Surfactants, reported multiple equity-based compensation awards. On March 2, 2026, he received 4,495 restricted stock units, 2,247 performance shares, and 6,440 stock appreciation rights with a $50.06 exercise price. On February 27, 2026, he also acquired 56.765 shares of common stock as an award. The filing shows 14,205.2335 common shares held directly and 4,478.351 shares held indirectly through an ESOP II trust as of that date. This Form 4/A amends a prior filing solely to correct the stock appreciation right exercise price from $17.47 to $50.06; all other terms remain unchanged.

Insider Trade Summary

Grant/Award: 13,238.765 shares

Grant/Award 5 txns

Insider Moriarty Sean Thomas

Role VP & GM Surfactants

Type	Security	Shares	Price	Value
Grant/Award	Stock Appreciation Right	6,440	$0.00	$0.00
Grant/Award	Performance Shares	2,247	$0.00	$0.00
Grant/Award	Restricted Stock Units	4,495	$0.00	$0.00
Grant/Award	Common Stock	56.765	$52.51	$3K
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Appreciation Right — 6,440 contracts (Direct); Performance Shares — 2,247 contracts (Direct); Restricted Stock Units — 4,495 contracts (Direct); Common Stock — 14,205.2335 shares (Direct); Common Stock — 4,478.351 shares (Indirect, By ESOP II Trust)

Footnotes (5)

1. F1. This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026 (the "Original Filing"). The Original Filing inadvertently reported an incorrect stock appreciation right ("SAR") conversion/exercise price due to an administrative error in the pricing calculation. The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported. This amendment corrects the reported conversion/exercise price. No other aspects of the reported transaction are affected.
2. F2. Vest ratably over three years beginning on the date shown.
3. F3. Each performance share represents a contingent right to receive one share of Stepan Company common stock.
4. F4. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
5. F5. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.

Key Figures

Restricted stock units granted: 4,495 units Performance shares granted: 2,247 shares Stock appreciation rights granted: 6,440 rights +4 more

7 metrics

Restricted stock units granted 4,495 units Grant on March 2, 2026; vest over three years

Performance shares granted 2,247 shares Grant on March 2, 2026; performance period to Dec. 31, 2028

Stock appreciation rights granted 6,440 rights Grant on March 2, 2026; derivative award

SAR exercise price $50.06 per share Corrected from $17.47 in amended Form 4/A

Direct common shares after award 14,205.2335 shares Direct holdings as of February 27, 2026

Indirect ESOP II Trust shares 4,478.351 shares Indirect holdings as of February 27, 2026

Common stock award 56.765 shares at $52.51 Grant on February 27, 2026

Key Terms

Stock Appreciation Right, Restricted Stock Units, performance shares, Form 4/A, +1 more

5 terms

Stock Appreciation Right financial

"The correct conversion/exercise price for the reported transaction is $50.06"

A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

performance shares financial

"Each performance share represents a contingent right to receive one share of Stepan Company common stock."

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Form 4/A regulatory

"This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026"

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

ESOP II Trust financial

"Common Stock ... 4478.3510 ... nature_of_ownership: By ESOP II Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did STEPAN CO (SCL) report in this Form 4/A?

STEPAN CO reported equity compensation awards to executive Sean Thomas Moriarty. He received restricted stock units, performance shares, stock appreciation rights, and a small common stock grant, reflecting routine stock-based compensation rather than open-market buying or selling.

How many restricted stock units did Sean Moriarty receive at STEPAN CO (SCL)?

Sean Moriarty received 4,495 restricted stock units. Each RSU represents a contingent right to one share of Stepan Company common stock, vesting ratably over three years beginning on the grant date, according to the filing footnotes.

What performance share award did STEPAN CO (SCL) grant to Sean Moriarty?

STEPAN CO granted 2,247 performance shares to Sean Moriarty. Each performance share can convert into one common share if Stepan Company meets specified performance goals for the period ending December 31, 2028, as described in the footnotes.

What are the key terms of Sean Moriarty’s stock appreciation rights at STEPAN CO (SCL)?

He was awarded 6,440 stock appreciation rights with a $50.06 exercise price. These rights are exercisable beginning March 2, 2027 and expire on March 3, 2036, providing potential value if the stock trades above the exercise price.

Why did STEPAN CO (SCL) file an amended Form 4/A for Sean Moriarty?

The amendment corrects an administrative error in the original filing. It changes the stock appreciation right exercise price from $17.47 to $50.06. The company states that no other aspects of the previously reported transaction are affected.

How many STEPAN CO (SCL) common shares does Sean Moriarty hold after these transactions?

After the reported transactions, he holds 14,205.2335 common shares directly. The filing also shows an additional 4,478.351 shares held indirectly through the ESOP II Trust, providing context for his overall equity exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 07:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moriarty Sean Thomas

(Last) (First) (Middle)

1101 SKOKIE BOULEVARD, SUITE 500

(Street)

NORTHBROOK ILLINOIS 60062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STEPAN CO [ SCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP & GM Surfactants

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/04/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		56.765	A	$52.51	14,205.2335	D
Common Stock								4,478.351	I	By ESOP II Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$50.06(1)	03/02/2026		A		6,440		03/02/2027(2)	03/03/2036	Common Stock	6,440	$0	6,440	D
Performance Shares	(3)	03/02/2026		A		2,247		(4)	(4)	Common Stock	2,247	$0	2,247	D
Restricted Stock Units	(5)	03/02/2026		A		4,495		03/02/2027(2)	03/02/2029	Restricted Stock Units	4,495	$0	4,495	D

Explanation of Responses:

1. This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026 (the "Original Filing"). The Original Filing inadvertently reported an incorrect stock appreciation right ("SAR") conversion/exercise price due to an administrative error in the pricing calculation. The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported. This amendment corrects the reported conversion/exercise price. No other aspects of the reported transaction are affected.

2. Vest ratably over three years beginning on the date shown.

3. Each performance share represents a contingent right to receive one share of Stepan Company common stock.

4. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.

5. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.

	/s/ James A. Hart, Attorney-in-Fact for Sean T. Moriarty	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)